According to WiseGuy Reports, the IHC Antibody Market was estimated at USD 9.9 billion in 2024 and increased to USD 10.3 billion in 2025. The industry is expected to reach USD 15.0 billion by 2035 while expanding at a CAGR of 3.8%. Growth is being driven by the rising prevalence of cancer, increasing diagnostic requirements, advances in antibody engineering, expanding biotechnology investments,...